Top Research Reports for Eli Lilly, Linde & Caterpillar

17.04.24 23:10 Uhr

Werte in diesem Artikel
Aktien

320,50 EUR -2,50 EUR -0,77%

400,00 EUR -3,60 EUR -0,89%

Indizes

PKT PKT

PKT PKT

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

39.069,6 PKT 4,3 PKT 0,01%

164,2 PKT 1,0 PKT 0,62%

524,0 PKT 2,2 PKT 0,43%

10.006,2 PKT 44,7 PKT 0,45%

18.808,4 PKT 185,0 PKT 0,99%

15.255,7 PKT 7,0 PKT 0,05%

7.395,0 PKT 32,1 PKT 0,44%

2.533,1 PKT 17,9 PKT 0,71%

5.304,7 PKT 36,9 PKT 0,70%

18.795,7 PKT 94,7 PKT 0,51%

Wednesday, April 17, 2024The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Co. (LLY), Linde plc (LIN) and Caterpillar Inc. (CAT). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>>Eli Lilly's shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+101.8% vs. +15.6%). The Zacks analyst believes that a solid portfolio of drugs for cancer, diabetes and autoimmune diseases and a solid pipeline for drugs in the area of obesity and Alzheimer’s have been helping the company’s growth.Yet, generic competition for some drugs, rising pricing pressure and challenges in meeting strong demand for incretin products like Trulicity are some top-line headwinds.(You can read the full research report on Eli Lilly here >>>)Linde’s shares have outperformed the Zacks Chemical – Specialty industry over the last six months (+20.0% vs. -7.9%). The Zacks analyst believes that stable cash flows arising out of long-term contracts with on-site customers and a substantial backlog have ensured that the company’s earning potential keeps climbing.However, rising competition for new projects in emerging markets remains a concern. The decrease in U.S. industrial production is also expected to reduce the demand for industrial gases, affecting profits.(You can read the full research report on Linde here >>>)Shares of Caterpillar have outperformed the Zacks Manufacturing – Construction and Mining industry over the past year (+59.8% vs. +57.2%). Per the Zacks analyst, the company’s cost-saving actions, strong end-market demand and pricing moves have offset the impact of the supply-chain interruptions and cost pressures. Rising global construction activity has also been a major tailwind.Yet, slowdown of the Chinese real estate sector and higher cost of materials remain concerns.(You can read the full research report on Caterpillar here >>>)Other noteworthy reports we are featuring today include Salesforce, Inc. (CRM), Wells Fargo & Co. (WFC) and Arista Networks, Inc. (ANET).Mark VickerySenior EditorNote: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>Today's Must ReadLilly (LLY) New Products Hold Key to Long-Term GrowthLinde's (LIN) Long-Term Contracts With Minimum Volume AidCaterpillar (CAT) to Gain on Strong Demand in End MarketsFeatured ReportsRising Commercial Demand Aids HEICO (HEI), Supply Chain AilsPer the Zacks analyst, HEICO enjoys an increasing demand due to the recovering commercial air travel worldwide. Yet, disruptions, delays and shortages in the global supply chain impacts performance.Old Dominion (ODFL) Strong on Dividends Amid Revenue WoesThe Zacks analyst likes the company's efforts to reward its shareholders. However, below-par revenues due to the weak freight demand scenario remain a concern.Digital Transformation and Acquisitions Aid Salesforce (CRM)Per the Zacks analyst, Salesforce is benefiting from ongoing digital transformations and the adoption of its cloud services. Moreover, strategic acquisitions like Slack and Tableau are positive.IDEXX (IDXX) Rides on Strong global growth, Forex Woe AilsThe Zacks analyst is impressed with IDEXX's global premium installed base, reflecting gains across the Catalyst, Premium Hematology, and SediVue platforms. Forex woes remain a concern.Carnival (CCL) Banks on Booking Improvements, High Costs AilPer the Zacks analyst, Carnival benefits from solid demand, robust booking volumes and advertising activities. However, increased cruise costs and geopolitical uncertainty are concerns.NVR's Disciplined Business Model & Rising Demand Bode WellPer the Zacks analyst, NVR is benefiting from a disciplined business model and solid housing market demand.Humana (HUM) Gains From Solid Membership Levels Amid High CostsPer the Zacks Analyst, robust Individual Medicare Advantage membership, courtesy of several contract wins, should aid Humana's top line. However, escalating expenses continue to weigh on margins.New UpgradesCorcept (CORT) Rides on Robust Korlym Sales PerformancePer the Zacks analyst, Corcept's sole drug, Korlym, approved for treating Cushing's syndrome, is driving the top-line. The company is also making good progress with its promising pipeline candidates.Arista (ANET) Rides on Robust Demand & Portfolio StrengthPer the Zacks analyst, healthy traction in the cloud networking vertical will likely boost Arista's top line. Easing of supply chain anomalies and steady improvement in gross margin are tailwinds.Wells Fargo (WFC) Rides on Deposit Growth & Solid LiquidityPer the Zacks analyst, Wells Fargo is set to benefit from deposit growth and efforts to manage expenses efficiently. Also, its solid liquidity position supports capital distribution activities.New DowngradesHigh Costs, Volatile Iron Ore Price Ail National Steel (SID)The Zacks analyst is concerned that the recent volatility in iron ore prices and higher costs for raw materials and fuel rising will weigh on National Steel's margins.Hibbett (HIBB) Witnesses Inflationary Pressures & Weak MarginsPer Zacks analyst, Hibbett is witnessing muted discretionary spend due to inflationary pressures. Gross margin fell in fourth quarter on lower average product margin and higher store-occupancy costs.Lower Prices, Operational Constraints Ail Methanex (MEOH)Per the Zacks analyst, operational issues, including facility turnarounds, will impact the company's production. Lower methanol prices will also hurt its margins.Free Report – The Bitcoin Profit PhenomenonZacks Investment Research has released a Special Report to help you pursue massive profits from the world’s first and largest decentralized form of money.No guarantees for the future, but in the past three presidential election years, Bitcoin’s returns were as follows: 2012 +272.4%, 2016 +161.1%, and 2020 +302.8%.Zacks predicts another significant surge. Click below for Bitcoin: A Tumultuous Yet Resilient History.Download Now – Today It’s FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Wells Fargo & Company (WFC): Free Stock Analysis Report Salesforce Inc. (CRM): Free Stock Analysis Report Caterpillar Inc. (CAT): Free Stock Analysis Report Eli Lilly and Company (LLY): Free Stock Analysis Report Linde PLC (LIN): Free Stock Analysis Report Arista Networks, Inc. (ANET): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Caterpillar

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Caterpillar

NameHebelKOEmittent
NameHebelKOEmittent
Werbung

Quelle: Zacks

Nachrichten zu Linde plc

Analysen zu Linde plc

DatumRatingAnalyst
19:01Linde OutperformBernstein Research
06.05.2024Linde BuyJefferies & Company Inc.
03.05.2024Linde KaufenDZ BANK
27.03.2024Linde NeutralUBS AG
07.03.2024Linde BuyUBS AG
DatumRatingAnalyst
19:01Linde OutperformBernstein Research
06.05.2024Linde BuyJefferies & Company Inc.
03.05.2024Linde KaufenDZ BANK
07.03.2024Linde BuyUBS AG
07.02.2024Linde KaufenDZ BANK
DatumRatingAnalyst
27.03.2024Linde NeutralUBS AG
02.11.2021Linde HaltenNorddeutsche Landesbank (Nord/LB)
15.10.2021Linde HaltenNorddeutsche Landesbank (Nord/LB)
03.08.2021Linde HaltenNorddeutsche Landesbank (Nord/LB)
01.04.2021Linde HaltenIndependent Research GmbH
DatumRatingAnalyst
07.02.2023Linde ReduceBaader Bank
19.01.2023Linde ReduceBaader Bank
27.10.2022Linde ReduceBaader Bank
25.10.2022Linde ReduceBaader Bank
18.10.2022Linde ReduceBaader Bank

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Linde plc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"